10.350
−1,43%
2026-10-19
Fundamental Analysis
35 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -45.6% | +43.7% | 1 / 3 | +0.9% | +0.78 pp | -0.84 pp | +8.9% | 0.83 | 8.58 | 1.488 | +0,9% | 14,6 | −45,6% | 8.58 | 8.31 | +3,2% |
| Pts | 0 | 8 | 4 | 0 | 8 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 10.350 (close price on 2026-10-19)EPS (TTM): 1.206
Financial charts
1.Revenue & growth
VND bn1.488Q2/26
1.Revenue & growth
VND bn1.488Q2/26
2.Profit & growth
VND bn14,5Q2/26
3.Profit mix (Penman)
VND bn103Q2/26
4.Margins & cost structure
%4.3%Q2/26
5.Returns & cash cycle
% · days5.1%Q2/26
6.Earnings quality & cash
VND bn244Q2/26
7.Asset structure
VND bn2.330Q2/26
8.Funding & debt health
VND bn · times2.330Q2/26
9.Revenue backlog
VND bn3,20Q2/26
10.Valuation
times · %9,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %215Q2/26
Adjusted EPS growth, latest quarter
-45.7%
Average adjusted EPS growth, 3 quarters
43.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26